Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Cheifetz

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
Expert Review of Gastroenterology & Hepatology|November 15, 2025
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
Therapeutic Advances in Chronic Disease|April 3, 2019
Infliximab in inflammatory bowel diseaseKonstantinos Papamichael, Steve Lin, Matthew Moore, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2024
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's DiseaseKonstantinos Papamichael, Andrea Centritto, Lucas Guillo, et al.
The American Journal of Gastroenterology|August 4, 2012
Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximabJason Ferreira, Jared Grochowsky, Douglas Krakower, et al.
Inflammatory Bowel Diseases|March 6, 2015
Utility of CT in the emergency department in patients with ulcerative colitisLaurie Gashin, Javier Villafuerte-Galvez, Daniel A Leffler, et al.
The American Journal of Gastroenterology|January 9, 2023
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH TrialAdam S Cheifetz, Niels Vande Casteele, Zhongya Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Seminars in Arthritis and Rheumatism|November 3, 2015
Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelinesJoseph D Feuerstein, Jonathan R Pelsis, Samuel Lloyd, et al.
Clinical Immunology (Orlando, Fla.)|March 31, 2018
Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivationWilliam T Clarke, Shreya S Amin, Konstantinos Papamichael, et al.
Journal of Managed Care & Specialty Pharmacy|February 26, 2014
Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysisJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Expert Review of Gastroenterology & Hepatology|November 15, 2025
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Tina Deyhim, et al.
Therapeutic Advances in Chronic Disease|April 3, 2019
Infliximab in inflammatory bowel diseaseKonstantinos Papamichael, Steve Lin, Matthew Moore, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2024
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's DiseaseKonstantinos Papamichael, Andrea Centritto, Lucas Guillo, et al.
The American Journal of Gastroenterology|August 4, 2012
Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximabJason Ferreira, Jared Grochowsky, Douglas Krakower, et al.
Inflammatory Bowel Diseases|March 6, 2015
Utility of CT in the emergency department in patients with ulcerative colitisLaurie Gashin, Javier Villafuerte-Galvez, Daniel A Leffler, et al.
The American Journal of Gastroenterology|January 9, 2023
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH TrialAdam S Cheifetz, Niels Vande Casteele, Zhongya Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Seminars in Arthritis and Rheumatism|November 3, 2015
Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelinesJoseph D Feuerstein, Jonathan R Pelsis, Samuel Lloyd, et al.
Clinical Immunology (Orlando, Fla.)|March 31, 2018
Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivationWilliam T Clarke, Shreya S Amin, Konstantinos Papamichael, et al.
Journal of Managed Care & Specialty Pharmacy|February 26, 2014
Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysisJennifer Devlen, Kathleen Beusterien, Linnette Yen, et al.
Pageof 21